➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Harvard Business School
Express Scripts
Merck
McKinsey

Last Updated: June 5, 2020

DrugPatentWatch Database Preview

Jubilant Draximage Company Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for JUBILANT DRAXIMAGE, and what generic and branded alternatives to JUBILANT DRAXIMAGE drugs are available?

JUBILANT DRAXIMAGE has nine approved drugs.



Summary for Jubilant Draximage
US Patents:0
Tradenames:11
Ingredients:8
NDAs:9

Drugs and US Patents for Jubilant Draximage

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Jubilant Draximage HICON sodium iodide i-131 SOLUTION;ORAL 021305-007 Dec 5, 2011 AA RX Yes Yes   Start Trial   Start Trial
Jubilant Draximage AN-DTPA technetium tc-99m pentetate kit INJECTABLE;INJECTION 017714-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Jubilant Draximage SODIUM FLUORIDE F-18 sodium fluoride f-18 INJECTABLE;INTRAVENOUS 203968-001 Oct 23, 2015 AP RX No No   Start Trial   Start Trial
Jubilant Draximage SODIUM IODIDE I 131 sodium iodide i-131 CAPSULE;ORAL 021305-006 May 19, 2005 RX Yes No   Start Trial   Start Trial
Jubilant Draximage DRAXIMAGE MDP-25 technetium tc-99m medronate INJECTABLE;INJECTION 018035-002 Feb 27, 2004 RX Yes Yes   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Colorcon
AstraZeneca
Merck
Mallinckrodt
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.